United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 589,200 | 417,900 | 713,700 | 651,600 | 340,100 |
| Depreciation Amortization | 35,900 | 31,000 | 31,600 | 32,900 | 32,200 |
| Accounts receivable | 121,400 | -82,700 | -21,700 | -30,500 | -35,700 |
| Accounts payable and accrued liabilities | -11,000 | 66,200 | 600 | 17,000 | -6,800 |
| Other Working Capital | 124,400 | -78,400 | -117,400 | -202,100 | -200,500 |
| Other Operating Activity | -81,500 | 120,200 | 36,800 | -86,100 | 226,000 |
| Operating Cash Flow | $778,400 | $474,200 | $643,600 | $382,800 | $355,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -732,000 | -757,700 | 129,600 | 257,600 | 430,900 |
| PPE Investments | -184,400 | -78,000 | -38,000 | -49,800 | -47,400 |
| Net Acquisitions | -124,100 | N/A | -5,200 | N/A | N/A |
| Purchase Of Investment | -46,000 | N/A | -38,100 | -54,200 | -45,000 |
| Sale Of Investment | 265,900 | N/A | N/A | 0 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | 350,000 | N/A |
| Other Investing Activity | 0 | 100 | 0 | 350,000 | 0 |
| Investing Cash Flow | $-820,600 | $-835,600 | $48,300 | $503,600 | $338,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250,000 | 250,000 | 0 | 0 | 140,000 |
| Debt Repayment | N/A | N/A | -8,800 | -133,200 | -177,800 |
| Common Stock Issued | 19,500 | 44,000 | 12,000 | 43,300 | 53,500 |
| Common Stock Repurchased | 0 | -250,000 | -500,000 | -394,500 | -483,100 |
| Other Financing Activity | -263,200 | -700 | -900 | 37,400 | -109,200 |
| Financing Cash Flow | $6,300 | $43,300 | $-497,700 | $-447,000 | $-576,600 |
| Exchange Rate Effect | N/A | 200 | -3,000 | -5,300 | -3,800 |
| Beginning Cash Position | 705,100 | 1,023,000 | 831,800 | 397,700 | 284,300 |
| End Cash Position | 669,200 | 705,100 | 1,023,000 | 831,800 | 397,700 |
| Net Cash Flow | $-35,900 | $-317,900 | $191,200 | $434,100 | $113,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 778,400 | 474,200 | 643,600 | 382,800 | 355,300 |
| Capital Expenditure | -184,400 | -86,300 | -38,000 | -49,800 | -47,400 |
| Free Cash Flow | 594,000 | 387,900 | 605,600 | 333,000 | 307,900 |